AHRQ

The April 2016 issue of The Research Advocate is now online . Highlights from this month include : A summary of Research!America's 27th Annual Meeting of Members and Advocacy Awards Dinner, including a special insert on the award honorees. Federal policy update, including information on the appropriations process for the National Institutes of Health (NIH), National Science Foundation (NSF) and Agency for Healthcare Research and Quality (AHRQ). Member spotlight featuring the University of North Texas Health Science Center . Learn more about the Parkinson's Disease Foundation You Can Help Us #EndParkinsons campaign, which launched in April for Parkinson's Awareness Month. Pfizer has...
Dear Research Advocate: We celebrated steadfast advocates for research to improve health at last week’s Advocacy Awards Dinner; pictures are now available. Champions like Whitehead awardees Chairmen Blunt and Cole keep us energized in the fight for medical research, even in the face of its virtual absence on the presidential campaign trail. Indeed, Research!America Chairman, Hon. John Porter, urged everyone present to take it upon themselves, as advocates, to make it clear how vital this election is to the future of science, research, and health. Since this is the mission of Campaign for Cures and related Research!America election-year activities, we can help you in your advocacy! Our...
Dear Research Advocate: Despite their fierce partisan standoff regarding confirmation of a Supreme Court nominee, members of the Senate acted in a strongly bi partisan manner yesterday to confirm Robert M. Califf, M.D., as the new FDA Commissioner. Dr. Califf brings an accomplished career of expertise and insight to the position. The goals he has set include increasing patient involvement in the FDA regulatory process, streamlining clinical trials, and attracting and retaining the best scientists, according to STAT News . For more on Dr. Califf’s confirmation, please see my statement . Commissioner Califf will be joining us as a keynote speaker at Research!America’s Annual Meeting at noon...
Dear Research Advocate: As task force meetings for Vice President Biden’s “moonshot” initiative began this week, a new public opinion survey commissioned by Research!America showed that 50% of Americans favor a tax increase to fund cancer research. While this manner of funding the moonshot is not currently on the table, the survey finding underscores the high priority Americans place on curing cancer. The President told Majority Leader McConnell and Speaker Ryan that assuring resources for research, cancer in particular, is one of his five priorities for working across the aisle this year. His FY17 budget proposal -- scheduled for release next Tuesday -- will reportedly request additional...
This was an exceptional year for publicly-funded research projects. Investments in science led to a greater understanding of preventing and treating disease such as using genetic variants to identify people at risk for coronary heart disease and tailoring breast cancer treatments to avoid the need for chemotherapy. The National Institutes of Health (NIH) also supported the work of three Nobel Prize winners and clinical advances in cancer, heart disease, MS and many other conditions. The National Science Foundation (NSF) funded interdisciplinary projects including one that led to a holistic approach to strengthening the security and effectiveness of mobile medical applications . Evidence-...
Dear Research Advocate, This holiday season, Congress has delivered a most welcome package with plenty of trimmings for patients and all of us who care about the future of health. The bipartisan deal-making is complete. A final short-term spending measure, expiring Tuesday, December 22, allows the House and Senate time to review and pass a spending bill and tax package before adjourning for the year. These two major pieces of legislation represent a real win for research; the jumpstart we need to restore the NIH budget to robust annual growth and fuel a new era of medical innovation and global leadership in both public and private sectors. As federal policymakers consider how to vote on...
Dear Research Advocate, The current continuing resolution (CR) expires tomorrow. Congress has yet to reach agreement on FY16 appropriations, so they will buy more time to hammer out a funding package by passing another CR lasting til midnight Wednesday, December 16. The major sticking points at this moment are additional policy riders attached to the funding omnibus, spanning the spectrum from immigration and refugees to labor and environmental issues. As it looks right now, some research-related budgets stand to gain, while others face a less positive fate. There’s more on NIH in my interview with The Atlantic , and we continue to press for increases for CDC, FDA, AHRQ and NSF. Social,...
Dear Research Advocate, "Never Settle" is the empowering guiding theme used by Janssen Pharmaceuticals to underscore the emphasis the company places on innovation to benefit patients. In my visit to their Spring House, PA, site today to participate in a worldwide town hall, I was struck by how their theme epitomizes the advocacy drive and determination of Research!America and all our partners in advocacy for research. I was glad to report to Janssen's teams that more and more members of Congress are championing research and innovation to benefit patients worldwide. Consider the comments of Chairman Roy Blunt (R-MO) about the FY16 Senate “Labor-H” appropriations draft, which reportedly...
The November 2015 issue of The Research Advocate is now online . Highlights from this month's issue include: The 2016 Advocacy Award recipients are announced. A federal policy update with details on the budget and appropriations agenda in Congress. Register for a webinar featuring AHRQ director, Dr. Kronick. A member spotlight featuring Shire. How you can be involved in Public Health Thank You Day on November 23. Download the entire November 2015 Research Advocate as a PDF.
Dear Research Advocate: Now that the President has signed off on the budget agreement, Appropriations Committee leadership is negotiating to establish the dollar level for each appropriations subcommittee to work with. Given the December 11 deadline for action, the committees are already working to set allocations for each federal agency and program. Here is a list of the Twitter handles for each House and Senate appropriator, along with suggested tweets. Please take a minute to tweet these leaders on why it is so important to increase funding for NIH, CDC, FDA, AHRQ and NSF; federal agencies that help keep the wheels of science and medical progress turning! It’s a mistake to just assume...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor